24/02/2026
We are pleased to share that our team has published a comprehensive review entitled “The placental tryptophan pathway across gestation: implications for pregnancy outcomes” in Human Reproduction Update, currently ranked #1 in Obstetrics and Gynecology (Impact Factor 16.1).
This publication represents the outcome of research efforts that began in 2017, when our team started systematically investigating placental tryptophan metabolism. Since then, this work has grown into a coherent research line focused on understanding how the placenta regulates serotonin, melatonin, and kynurenine pathways, and how these metabolic processes shape pregnancy outcomes and fetal neurodevelopment.
Over the years, more than 15 experimental studies have been published in this field, combining human placental models, animal studies, molecular approaches, and clinical cohort data. This research has also formed the basis of three completed PhD projects, with a fourth currently ongoing, reflecting the continuity and academic depth of this work.
The newly published review integrates international evidence with findings generated within our team, providing a comprehensive framework for understanding how placental tryptophan metabolism changes across gestation and how its dysregulation may contribute to pregnancy complications such as preterm birth, preeclampsia, and fetal growth restriction. Particular attention is given to early pregnancy as a critical window during which metabolic balance is established and fetal exposure to neuroactive metabolites is determined.
We are proud to see this body of work synthesized in one of the leading journals in reproductive science.
AbstractBACKGROUND. Tryptophan metabolism within the placenta generates bioactive metabolites, including serotonin (5-hydroxytryptamine; 5-HT), melatonin,